Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization
Micro Cap Biotechnology Stocks at a Glance
Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.
There are 296 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $19.3B.
The largest by market cap are Clinuvel Pharmaceuticals (CUVL) at $249M, Cabaletta Bio (CABA) at $249M and Bicycle Therapeutics (BCYC) at $248M.
Among institutional investors, Eledon Pharmaceuticals (ELDN) drew the most net new fund positions in Q2 2026: 51 funds opened new positions, taking total fund holders up 40 (33%) quarter-over-quarter.
- Combined market cap: $19.3B across 296 stocks.
- Micro Cap: market cap under $250M.
- Largest constituent: Clinuvel Pharmaceuticals (CUVL), $249M market cap.
- Most net new fund positions in Q2 2026: Eledon Pharmaceuticals (ELDN), +40 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.